Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02996110
Title A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma (FRACTION-RCC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

renal cell carcinoma

Therapies

Nivolumab + Relatlimab

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.